Projects per year
Personal profile
Education
- 1996 PhD. Institute of Immunolgy, Harvard University, USA
Experience
- 1996.07~1997.01 Postdoctoral Research/Brigham and Women’s Hospital/Harvard University
- 1997.02~Present Attending Physician/Divisionof Pediatric Allergy and Immunology/National Cheng Kung University Hospital
- 1998.08~2002.07 Assistant Professor/Department of Microbiology and Immunology, NCKU
- 2002.03~2004.07 Head of Pediatric Allergy and Immunology Division/National Cheng Kung University Hospital
- 2002.08~2007.07 Associate Professor/Department of Microbiology and Immunology, NCKU
- 2007.08~2010.07 Professor/Department of Microbiology and Immunology, NCKU
- 2010.08~present Editor/ Journal of Microbiology, Immunology and Infection
- 2011.08~2017.07 Professor Director/ Graduate institute of clinical medicine & clinical medicine researcher center, NCKU
- 2011.08~Present Professor
- 2016.08~ Distinguished Professor
Research Interests
The research in Prof. Chi-Chang Shieh’s laboratory focuses on the immune mechanisms underlying the tissue inflammation of human diseases including allergic asthma, immune mediated arthritis and autoimmune reactions in immunodeficiency diseases.
His recent laboratory research took advantage of the resources in the campuses of National Cheng Kung University and Southern Facility of National Laboratory Animal Center, both located in Tainan City, to elucidate the molecular and cellular mechanism leading to tissue inflammation in patients with low production of reactive oxygen species (ROS). Moreover, he devised methods aimed to correct the low production of ROS by leukocytes, which is the cause of the primary immunodeficiency disease chronic granulomatous disease (CGD), using state-of-the-art technologies and cutting-edge knowledge in leukocyte biology.
The main accomplishments of his research are concisely described as follows:
1. To establish a clinic of human primary immunodeficiency for diagnosis, treatment and research for this group of difficult diseases.
2. To develop the research for secondary immunodeficiency 3. To unravel the mechanisms underlying redox regulation of immune responses 4. Development of organelle-specific treatment for immunological diseases
His recent laboratory research took advantage of the resources in the campuses of National Cheng Kung University and Southern Facility of National Laboratory Animal Center, both located in Tainan City, to elucidate the molecular and cellular mechanism leading to tissue inflammation in patients with low production of reactive oxygen species (ROS). Moreover, he devised methods aimed to correct the low production of ROS by leukocytes, which is the cause of the primary immunodeficiency disease chronic granulomatous disease (CGD), using state-of-the-art technologies and cutting-edge knowledge in leukocyte biology.
The main accomplishments of his research are concisely described as follows:
1. To establish a clinic of human primary immunodeficiency for diagnosis, treatment and research for this group of difficult diseases.
2. To develop the research for secondary immunodeficiency 3. To unravel the mechanisms underlying redox regulation of immune responses 4. Development of organelle-specific treatment for immunological diseases
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Chi-Chang Shieh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 24 Finished
-
Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Chen, C. J., Wang, H. C., Hou, Y. C., Wu, Y. Y., Shieh, C. C. & Shan, Y. S., 2024 Jul, In: Molecular cancer therapeutics. 23, 7, p. OF1-OF15Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
High occurrence of autoimmune and lymphoproliferative manifestations in adults with common variable immunodeficiency in southern Taiwan
Wang, C. R., Tsai, H. W. & Shieh, C. C., 2024 Dec, In: Journal of the Formosan Medical Association. 123, 12, p. 1311-1315 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Monocentric study of IL-5 monoclonal antibody induction therapy for eosinophilic granulomatosis with polyangiitis
Wang, C. R., Tsai, H. W. & Shieh, C. C., 2024 Jul, In: Journal of the Formosan Medical Association. 123, 7, p. 802-810 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Age and prior vaccination determine the antibody level in children with primary SARS-CoV-2 Omicron infection
Taiwan Pediatric Infectious Disease Alliance (TPIDA), 2023 Dec, In: Journal of Microbiology, Immunology and Infection. 56, 6, p. 1187-1197 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expression
Kuo, C. W., Su, P. L., Huang, T. H., Lin, C. C., Chen, C. W., Tsai, J. S., Liao, X. M., Chan, T. Y. & Shieh, C. C., 2023 Dec, In: Scientific reports. 13, 1, 7894.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)